Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TKPHF) Other Non-Current Assets (2017 - 2025)

Historic Other Non-Current Assets for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to $505.4 million.

  • Takeda Pharmaceutical's Other Non-Current Assets rose 361.74% to $505.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $505.4 million, marking a year-over-year increase of 361.74%. This contributed to the annual value of $461.4 million for FY2025, which is 2992.38% up from last year.
  • Latest data reveals that Takeda Pharmaceutical reported Other Non-Current Assets of $505.4 million as of Q4 2025, which was up 361.74% from $478.7 million recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Other Non-Current Assets high stood at $948.0 million for Q1 2021, and its period low was $345.6 million during Q1 2024.
  • For the 5-year period, Takeda Pharmaceutical's Other Non-Current Assets averaged around $575.0 million, with its median value being $496.6 million (2025).
  • Per our database at Business Quant, Takeda Pharmaceutical's Other Non-Current Assets tumbled by 3297.36% in 2023 and then surged by 5530.35% in 2024.
  • Quarter analysis of 5 years shows Takeda Pharmaceutical's Other Non-Current Assets stood at $700.7 million in 2021, then plummeted by 32.54% to $472.6 million in 2022, then decreased by 21.7% to $370.1 million in 2023, then skyrocketed by 31.81% to $487.8 million in 2024, then increased by 3.62% to $505.4 million in 2025.
  • Its Other Non-Current Assets was $505.4 million in Q4 2025, compared to $478.7 million in Q3 2025 and $473.8 million in Q2 2025.